Myriad Genetics Balance Sheet Health
Financial Health criteria checks 5/6
Myriad Genetics has a total shareholder equity of $916.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.2B and $295.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$193.20m |
Equity | US$916.60m |
Total liabilities | US$295.40m |
Total assets | US$1.21b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MYD's short term assets ($352.3M) exceed its short term liabilities ($129.1M).
Long Term Liabilities: MYD's short term assets ($352.3M) exceed its long term liabilities ($166.3M).
Debt to Equity History and Analysis
Debt Level: MYD is debt free.
Reducing Debt: MYD has no debt compared to 5 years ago when its debt to equity ratio was 8.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MYD has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if MYD has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.